Positive results from the world’s first clinical trial testing the potential for cannabidiol (CBD) to treat cannabis addiction suggest daily use of medical-grade CBD is both safe and effective at reducing problematic cannabis consumption.The results of the phase 2a, double-blind and placebo-controlled trial were published in The Lancet Psychiatry. The first phase of the trial…
Positive outcomes from the world’s first medical trial checking the capacity for cannabidiol (CBD) to treat marijuana addiction suggest daily use of medical-grade CBD is both safe and efficient at reducing problematic marijuana usage.
” Our findings indicate that CBD doses varying from 400 mg to 800 mg daily have the prospective to reduce cannabis usage in clinical settings, but greater dosages are not likely to bring any extra benefit,” describes Valerie Curran, senior author on the brand-new study.
” Whilst it may seem counterproductive to treat bothersome cannabis use with CBD– a constituent part of the marijuana plant– THC and CBD have contrasting impacts on our own endogenous cannabinoid system,” state Tom Freeman, lead author on the new study.